Evidence map›Paper›PMID 33271215›Full record

ArticleThe Journal of hospital infection2021

Implementation of the infection prevention and control core components at the national level: a global situational analysis.

E Tartari, S Tomczyk, D Pires, B Zayed, A P Coutinho Rehse, P Kariyo, V Stempliuk, W Zingg, D Pittet, B Allegranzi

Open access · hybridAbstract read
In one paragraph

Article in The Journal of hospital infection, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 59 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed, 2 pooled it
1.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

59 citing papers in PubMed, 2 syntheses or guidelines pooled it, 103 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 4 countries.

E TartariInfection Prevention and Control Programme, Geneva University Hospitals, and Faculty of Medicine, Geneva, Switzerland; Institute of Global Health, Faculty of Medicine, University of Geneva, Geneva, Switzerland.
S TomczykInstitute of Global Health, Faculty of Medicine, University of Geneva, Geneva, Switzerland; Infection Prevention and Control Technical and Clinical Hub, Department of Integrated Health Services, World Health Organization (WHO), Geneva, Switzerland.
D PiresInfection Prevention and Control Programme, Geneva University Hospitals, and Faculty of Medicine, Geneva, Switzerland.
B ZayedWHO Antimicrobial Resistance and Infection Prevention and Control Unit, Regional Office for the Eastern Mediterranean, Cairo, Egypt.
A P Coutinho RehseHealth Emergencies Programme, WHO Regional Office for Europe, Copenhagen, Denmark.
P KariyoEquipe d'Appui Interpays pour l'Afrique Centrale, WHO Country Office, Libreville, Gabon.
V StempliukPan American Health Organization Office for Jamaica, Bermuda and the Cayman Islands, Kingston, Jamaica.
W ZinggInfection Prevention and Control Programme, Geneva University Hospitals, and Faculty of Medicine, Geneva, Switzerland.
D PittetInfection Prevention and Control Programme, Geneva University Hospitals, and Faculty of Medicine, Geneva, Switzerland.
B AllegranziInstitute of Global Health, Faculty of Medicine, University of Geneva, Geneva, Switzerland; Infection Prevention and Control Technical and Clinical Hub, Department of Integrated Health Services, World Health Organization (WHO), Geneva, Switzerland. Electronic address: allegranzib@who.int.
University Hospital of Geneva · CHUniversity of Geneva · CHUniversity of the West Indies · JMWorld Health Organization · CHWorld Health Organization Regional Office for Europe · DKWorld Health Organization Regional Office for the Eastern Mediterranean · EG

Funding

World Health Organization 001
6 · The paper itself

Abstract

backgroundStrengthening infection prevention and control (IPC) is essential to combat healthcare-associated infections, antimicrobial resistance, and to prevent and respond to outbreaks.

aimTo assess national IPC programmes worldwide according to the World Health Organization (WHO) IPC core components.

methodsBetween June 1

findingsEighty-eight of 103 (85.4%) eligible countries participated; 22.7% were low-income, 19.3% lower-middle-income, 23.9% upper-middle-income, and 34.1% high-income economies. A national IPC programme existed in 62.5%, but only 26.1% had a dedicated budget. National guidelines were available in 67.0%, but only 36.4% and 21.6% of countries had an implementation strategy and evaluated compliance with guidelines, respectively. Undergraduate IPC curriculum and in-service and postgraduate IPC training were reported by 35.2%, 54.5%, and 42% of countries, respectively. Healthcare-associated infection surveillance was reported by 46.6% of countries, with significant differences ranging from 83.3% (high-income) to zero (low-income) (P < 0.001); monitoring and feedback of IPC indicators was reported by 65.9%. Only 12.5% of countries had all core components in place.

conclusionMost countries have IPC programme and guidelines, but many less have invested adequate resources and translated them in implementation and monitoring, particularly in low-income countries. Leadership support at the national and global level is needed to achieve implementation of the core components in all countries.

Indexed as

Infection ControlCross InfectionCross-Sectional StudiesEpidemiological MonitoringHumansInternationalityWorld Health OrganizationAntimicrobial resistanceCore componentsHealthcare-associated infectionImplementationInfection prevention and controlWorld Health Organization

Identifiers

PMID33271215
PMCPMC7884929
OpenAlexW3109283454

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.